Editorial Board

Annals of Experimental and Molecular Biology

Home AEMB Editorial Board Tai Ming Ko

Share this profile

LinkedIn Twitter / X

✓ Link copied!

Tai Ming Ko

Tai Ming Ko

Editorial Board Member
National Chiao Tung University Taiwan Member since 2018

Biography

Tai Ming Ko has completed his Ph.D. from National Taiwan University, Taiwan. HE has received Honors, Awards & he had published articles in international journals. His current research is focused on two major projects: (1) pharmacogenomic and immunogenetic studies for serious adverse drug reactions, and (2) investigation of pathogenic factors contributing to Kawasaki disease, mainly apply multi-omics approaches and the developing technologies for analyzing highly polymorphic gene (i.e. HLA, TCR, KIR). In the past few years, he had identified new potential biomarkers or genetic factors for Kawasaki disease, serious adverse drug reactions, and stroke. Moreover, for preventing life-threatening cutaneous adverse drug reactions, he also contributed to translating biomarkers (HLA-B*58:01) into clinical practice through a large prospective study which demonstrated an example that pharmacogenomic approach could provide a strong basis for implementation of precision medicine.

Research Interests

Translational research and personalized medicine pharmacogenomics and molecular epidemiology

Other Editorial Board Members

Submit Manuscript

Chat with us on WhatsApp

Welcome to Medwin Publishers. How can we help you today?